Skip to search formSkip to main contentSkip to account menu

CTR9 gene

Known as: CTR9 homolog, Paf1/RNA polymerase II complex component, p150(TSP), SH2BP1 
This gene is involved in embryonic stem cell pluripotency, transcriptional elongation and histone modification.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Wilms tumour is a childhood kidney cancer. Here we identify inactivating CTR9 mutations in 3 of 35 Wilms tumour families, through… 
Highly Cited
2013
Highly Cited
2013
BackgroundSeveral host-encoded antiviral factors suppress HIV-1 replication in a cell-autonomous fashion in vitro. The relevance… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Parafibromin, the product of the HRPT2 (hyperparathyroidism-jaw tumor syndrome 2) tumor suppressor gene, is the human… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Inactivation of the HRPT2 tumor suppressor gene is associated with the pathogenesis of the hereditary… 
2005
2005
Previous work has shown that a protein extract enriched for cysteine protease activity (TSBP) prepared from adult Haemonchus… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT The Saccharomyces cerevisiae Paf1-RNA polymerase II (Pol II) complex is biochemically and functionally distinct from the… 
1996
1996
Src homology 2 (SH2) domains are structural modules that function in the assembly of multicomponent signaling complexes by…